Physician profile
Sandhya Venugopal
NPI 1013921253
$1,350.38
in general payments reported to CMS, 2019-2025
20 companies · $173 in 2025
The $173 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $256 · 2020: $185 · 2021: $114 · 2022: $409 · 2023: $32.52 · 2024: $181 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $386.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Recor Medical INC | $281.81 | 2024-2025 | Paradise Ultrasound Renal Denervation System, Paradise Renal Denervation System |
| Biotronik INC. | $230.66 | 2019-2022 | |
| Amgen INC. | $145.36 | 2019-2021 | |
| Pfizer INC. | $120.32 | 2019-2022 | |
| Medtronic, INC. | $86.20 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $55.20 | 2019 | |
| Janssen Pharmaceuticals, INC | $53.00 | 2020 | |
| Ge Healthcare | $51.42 | 2020 | |
| Irhythm Technologies, INC. | $47.61 | 2024 | Zio Xt Patch, Zio Monitor |
| Shockwave Medical, INC | $44.23 | 2021-2022 | |
| Abbott Laboratories | $36.80 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $34.27 | 2019 | |
| Abiomed | $28.29 | 2021 | |
| Edwards Lifesciences Corporation | $24.38 | 2025 | Pascal |
| Angiodynamics, INC. | $21.50 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.83 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $19.04 | 2020 | |
| Novartis Pharmaceuticals Corporation | $17.66 | 2023 | |
| Sanofi-Aventis U.S. LLC | $16.94 | 2020 | |
| Heartflow, INC. | $14.86 | 2023 | Ffrct |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandhya Venugopal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.